Ultravate (Ranbaxy Laboratories, Inc.)
Welcome to the PulseAid listing for the Ultravate drug offered from Ranbaxy Laboratories, Inc.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ranbaxy Laboratories, Inc. |
| NON-PROPRIETARY NAME: | halobetasol propionate |
| SUBSTANCE NAME: | HALOBETASOL PROPIONATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | LOTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-03-01 |
| END MARKETING DATE: | 0000-00-00 |
Ultravate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ultravate from Ranbaxy Laboratories, Inc. |
| LABELER NAME: | Ranbaxy Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/g) |
| START MARKETING DATE: | 2016-03-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10631-122_1e0e23af-03ba-4520-ab13-7544e0c6a7f1 |
| PRODUCT NDC: | 10631-122 |
| APPLICATION NUMBER: | NDA208183 |
Other HALOBETASOL PROPIONATE Pharmaceutical Manufacturers / Labelers:
